Chlorine in PDB 5wyn: HTRA2 Pathogenic Mutant
Enzymatic activity of HTRA2 Pathogenic Mutant
All present enzymatic activity of HTRA2 Pathogenic Mutant:
3.4.21.108;
Protein crystallography data
The structure of HTRA2 Pathogenic Mutant, PDB code: 5wyn
was solved by
A.R.Wagh,
K.Bose,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
42.82 /
2.05
|
Space group
|
H 3
|
Cell size a, b, c (Å), α, β, γ (°)
|
85.646,
85.646,
126.306,
90.00,
90.00,
120.00
|
R / Rfree (%)
|
15.3 /
18.5
|
Chlorine Binding Sites:
The binding sites of Chlorine atom in the HTRA2 Pathogenic Mutant
(pdb code 5wyn). This binding sites where shown within
5.0 Angstroms radius around Chlorine atom.
In total 6 binding sites of Chlorine where determined in the
HTRA2 Pathogenic Mutant, PDB code: 5wyn:
Jump to Chlorine binding site number:
1;
2;
3;
4;
5;
6;
Chlorine binding site 1 out
of 6 in 5wyn
Go back to
Chlorine Binding Sites List in 5wyn
Chlorine binding site 1 out
of 6 in the HTRA2 Pathogenic Mutant
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 1 of HTRA2 Pathogenic Mutant within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Cl401
b:56.9
occ:1.00
|
N
|
A:TYR161
|
3.7
|
35.1
|
1.0
|
CA
|
A:GLU160
|
4.1
|
43.1
|
1.0
|
NE2
|
A:GLN163
|
4.2
|
43.9
|
1.0
|
C
|
A:GLU160
|
4.2
|
41.2
|
1.0
|
O
|
A:TYR161
|
4.3
|
33.3
|
1.0
|
CD2
|
A:TYR161
|
4.4
|
38.2
|
1.0
|
CB
|
A:TYR161
|
4.5
|
32.0
|
1.0
|
O
|
A:VAL159
|
4.5
|
49.4
|
1.0
|
CA
|
A:TYR161
|
4.5
|
33.5
|
1.0
|
CD1
|
A:ILE240
|
4.7
|
44.7
|
1.0
|
CB
|
A:GLU160
|
4.7
|
43.3
|
1.0
|
C
|
A:TYR161
|
4.9
|
30.6
|
1.0
|
CG
|
A:TYR161
|
5.0
|
34.4
|
1.0
|
|
Chlorine binding site 2 out
of 6 in 5wyn
Go back to
Chlorine Binding Sites List in 5wyn
Chlorine binding site 2 out
of 6 in the HTRA2 Pathogenic Mutant
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 2 of HTRA2 Pathogenic Mutant within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Cl402
b:55.2
occ:1.00
|
O
|
A:HOH661
|
2.8
|
34.8
|
1.0
|
N
|
A:GLU160
|
3.5
|
46.1
|
1.0
|
O
|
A:HOH619
|
3.7
|
54.9
|
1.0
|
OD1
|
A:ASN158
|
3.8
|
67.2
|
1.0
|
CA
|
A:VAL159
|
4.0
|
47.8
|
1.0
|
CB
|
A:ARG204
|
4.0
|
29.9
|
1.0
|
CG
|
A:PRO201
|
4.1
|
26.9
|
1.0
|
O
|
A:ASN158
|
4.2
|
61.4
|
1.0
|
CD
|
A:ARG204
|
4.3
|
39.8
|
1.0
|
C
|
A:VAL159
|
4.3
|
45.6
|
1.0
|
NH1
|
A:ARG204
|
4.4
|
43.9
|
1.0
|
O
|
A:GLU160
|
4.4
|
41.0
|
1.0
|
CA
|
A:GLU160
|
4.4
|
43.1
|
1.0
|
CD
|
A:PRO201
|
4.4
|
26.7
|
1.0
|
CG
|
A:ARG204
|
4.5
|
35.6
|
1.0
|
C
|
A:ASN158
|
4.5
|
58.1
|
1.0
|
CB
|
A:GLU160
|
4.5
|
43.3
|
1.0
|
N
|
A:VAL159
|
4.5
|
51.3
|
1.0
|
CG
|
A:ASN158
|
4.7
|
70.1
|
1.0
|
C
|
A:GLU160
|
4.7
|
41.2
|
1.0
|
CB
|
A:PRO201
|
4.9
|
26.3
|
1.0
|
CB
|
A:ASN158
|
4.9
|
62.0
|
1.0
|
|
Chlorine binding site 3 out
of 6 in 5wyn
Go back to
Chlorine Binding Sites List in 5wyn
Chlorine binding site 3 out
of 6 in the HTRA2 Pathogenic Mutant
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 3 of HTRA2 Pathogenic Mutant within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Cl403
b:72.2
occ:1.00
|
O
|
A:VAL263
|
3.6
|
43.9
|
1.0
|
CD2
|
A:LEU265
|
3.8
|
51.5
|
1.0
|
CD
|
A:PRO276
|
3.8
|
34.2
|
1.0
|
CB
|
A:VAL263
|
3.9
|
34.0
|
1.0
|
CG
|
A:PRO276
|
4.2
|
38.9
|
1.0
|
CG1
|
A:VAL263
|
4.4
|
39.5
|
1.0
|
C
|
A:VAL263
|
4.5
|
39.6
|
1.0
|
CA
|
A:VAL263
|
4.7
|
40.1
|
1.0
|
N
|
A:VAL263
|
4.8
|
40.0
|
1.0
|
CG2
|
A:VAL263
|
4.8
|
34.6
|
1.0
|
|
Chlorine binding site 4 out
of 6 in 5wyn
Go back to
Chlorine Binding Sites List in 5wyn
Chlorine binding site 4 out
of 6 in the HTRA2 Pathogenic Mutant
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 4 of HTRA2 Pathogenic Mutant within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Cl404
b:60.0
occ:1.00
|
N
|
A:LEU265
|
3.2
|
43.2
|
1.0
|
O
|
A:HOH565
|
3.6
|
57.9
|
1.0
|
CA
|
A:ILE264
|
3.6
|
38.6
|
1.0
|
O
|
A:HOH501
|
3.8
|
41.8
|
1.0
|
CG2
|
A:ILE264
|
3.9
|
40.0
|
1.0
|
CG
|
A:LEU265
|
3.9
|
49.6
|
1.0
|
C
|
A:ILE264
|
3.9
|
40.5
|
1.0
|
O
|
A:VAL263
|
4.1
|
43.9
|
1.0
|
CB
|
A:LEU265
|
4.1
|
46.4
|
1.0
|
CB
|
A:ILE264
|
4.2
|
38.6
|
1.0
|
CA
|
A:LEU265
|
4.3
|
43.9
|
1.0
|
O
|
A:ILE46
|
4.5
|
40.4
|
1.0
|
CD2
|
A:LEU265
|
4.5
|
51.5
|
1.0
|
N
|
A:ILE264
|
4.6
|
37.0
|
1.0
|
CG1
|
A:ILE264
|
4.7
|
40.1
|
1.0
|
C
|
A:VAL263
|
4.8
|
39.6
|
1.0
|
O
|
A:HOH518
|
4.9
|
46.7
|
1.0
|
|
Chlorine binding site 5 out
of 6 in 5wyn
Go back to
Chlorine Binding Sites List in 5wyn
Chlorine binding site 5 out
of 6 in the HTRA2 Pathogenic Mutant
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 5 of HTRA2 Pathogenic Mutant within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Cl405
b:63.0
occ:1.00
|
ND1
|
A:HIS261
|
3.0
|
35.7
|
1.0
|
CD1
|
A:LEU259
|
3.4
|
42.0
|
1.0
|
O
|
A:HOH663
|
3.6
|
62.5
|
1.0
|
CE1
|
A:HIS261
|
3.9
|
36.8
|
1.0
|
CG
|
A:HIS261
|
3.9
|
37.8
|
1.0
|
O
|
A:VAL192
|
3.9
|
44.3
|
1.0
|
CB
|
A:HIS261
|
4.1
|
34.0
|
1.0
|
O
|
A:LYS191
|
4.2
|
36.1
|
1.0
|
CA
|
A:HIS261
|
4.4
|
35.0
|
1.0
|
CA
|
A:VAL192
|
4.5
|
41.0
|
1.0
|
CG
|
A:LEU259
|
4.5
|
41.5
|
1.0
|
C
|
A:VAL192
|
4.6
|
41.7
|
1.0
|
O
|
A:HOH644
|
4.9
|
56.3
|
1.0
|
CD2
|
A:LEU244
|
5.0
|
46.0
|
1.0
|
CG1
|
A:VAL192
|
5.0
|
39.7
|
1.0
|
CD2
|
A:LEU234
|
5.0
|
42.7
|
1.0
|
|
Chlorine binding site 6 out
of 6 in 5wyn
Go back to
Chlorine Binding Sites List in 5wyn
Chlorine binding site 6 out
of 6 in the HTRA2 Pathogenic Mutant
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 6 of HTRA2 Pathogenic Mutant within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Cl406
b:40.7
occ:1.00
|
N
|
A:GLY230
|
3.0
|
31.4
|
1.0
|
N
|
A:ILE229
|
3.2
|
35.6
|
1.0
|
O
|
A:HOH660
|
3.3
|
60.5
|
1.0
|
O
|
A:HOH664
|
3.4
|
49.0
|
1.0
|
CH2
|
A:TRP295
|
3.4
|
42.8
|
1.0
|
CZ3
|
A:TRP295
|
3.6
|
40.5
|
1.0
|
CD1
|
A:TYR228
|
3.6
|
36.5
|
1.0
|
CG1
|
A:ILE229
|
3.8
|
38.4
|
1.0
|
CA
|
A:GLY230
|
3.8
|
33.4
|
1.0
|
C
|
A:ILE229
|
4.0
|
37.4
|
1.0
|
CE1
|
A:TYR228
|
4.0
|
36.2
|
1.0
|
CA
|
A:ILE229
|
4.0
|
36.9
|
1.0
|
CA
|
A:TYR228
|
4.1
|
38.5
|
1.0
|
C
|
A:TYR228
|
4.1
|
41.1
|
1.0
|
N
|
A:VAL231
|
4.1
|
37.6
|
1.0
|
CG
|
A:TYR228
|
4.3
|
35.2
|
1.0
|
CB
|
A:PRO92
|
4.5
|
36.5
|
1.0
|
CB
|
A:ILE229
|
4.5
|
38.0
|
1.0
|
C
|
A:GLY230
|
4.5
|
38.8
|
1.0
|
O
|
A:VAL231
|
4.6
|
40.7
|
1.0
|
CB
|
A:TYR228
|
4.6
|
37.5
|
1.0
|
O
|
A:HOH540
|
4.7
|
40.8
|
1.0
|
CZ2
|
A:TRP295
|
4.7
|
39.4
|
1.0
|
O
|
A:HOH640
|
4.8
|
62.9
|
1.0
|
O
|
A:ARG227
|
4.9
|
49.7
|
1.0
|
CE3
|
A:TRP295
|
4.9
|
40.6
|
1.0
|
CD1
|
A:ILE229
|
4.9
|
38.9
|
1.0
|
|
Reference:
A.R.Wagh,
K.Bose.
Structural Basis of Inactivation of Human Counterpart of Mouse Motor Neuron Degeneration 2 Mutant in Serine Protease HTRA2 Biosci. Rep. V. 38 2018.
ISSN: ISSN 1573-4935
PubMed: 30068699
DOI: 10.1042/BSR20181072
Page generated: Fri Jul 26 20:43:14 2024
|